Stay updated on Nivolumab Safety in Chinese Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 released, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:38:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2. The previously displayed government funding notice and the older Revision: v3.4.1 banner were removed.
    Difference
    0.4%
    Check dated 2026-02-11T16:22:57.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A notice about a lapse in government funding was added, informing users about potential delays and directing to cc.nih.gov and opm.gov for status updates. The page shows a new revision identifier, v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:52:20.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI/content updates: a glossary toggle is now shown and the QC criteria label capitalization was adjusted to 'Met QC Criteria'. The revision is updated to v3.4.0 and the No FEAR Act Data notice was added.
    Difference
    0.2%
    Check dated 2026-01-28T06:36:41.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section with Guangdong and Zhejiang as study sites, and the revision label has been updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:05:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Safety in Chinese Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Safety in Chinese Solid Tumors Clinical Trial page.